CSII - Cardiovascular Systems GAAP EPS of -$0.23 misses by $0.09 revenue of $59.1M misses by $3.56M cuts FY guidance

Cardiovascular Systems press release (NASDAQ:CSII): Q2 GAAP EPS of -$0.23 misses by $0.09. Revenue of $59.1M (-7.9% Y/Y) misses by $3.56M. For the fiscal year ending June 30, 2022, CSI anticipates: Revenue of $235 million to $245 million from prior guidance of $265 million to $285 million vs. $270.17M consensus. Gross profit as a percentage of approximately 73% of revenues; Net loss in a range of 15% to 18% of revenues; and Adjusted EBITDA loss in a range of 4% to 7% of revenues.

For further details see:

Cardiovascular Systems GAAP EPS of -$0.23 misses by $0.09, revenue of $59.1M misses by $3.56M, cuts FY guidance